sequencing

Collaboration to leverage Oxford Nanopore’s sequencing platform and Cepheid’s GeneXpert system to advance the field of sequencing for infectious diseases.

EpiCypher has launched meCUT&RUN and Multiomic CUT&RUN, two cost-effective tools for high-resolution DNA methylation and multiomic epigenomic profiling.

A small percentage of cells in healthy breast tissue show chromosomal abnormalities often linked to cancer, a finding with potential diagnostic implications.

Profiling over 100,000 genomes, researchers identified rare mutations associated with early menopause and cancer, and that some mutations pass down to children.

Researchers harness pharmacogenomics to understand why individual patients react differently to opioids for pain relief. 

Pharmacogenetics guides better psychiatric drug treatments.

In a journey that spanned the genomes of more than 150,000 Icelanders, archival samples, and a fetus in utero, researchers not only identified genetic variants missing from the population, but also proved that these missing mutations cause three rare genetic diseases.

What do 23andMe and Snapchat have in common? They both collect very personal information about their users. Do the benefits outweigh the risks?

Through many innovations over the past 40 years, ChIP rapidly evolved to become a powerful tool for understanding the epigenome.

Through many innovations over the past 40 years, ChIP rapidly evolved to become a powerful tool for understanding the epigenome.